about
Vilazodone for the Treatment of Depression: An UpdateManaging anxiety associated with neurodegenerative disordersThe Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.Developmental effects of serotonin 1A autoreceptors on anxiety and social behavior.Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.Vilazodone for the treatment of major depressive disorder: focusing on its clinical studies and mechanism of action.Levo-Tetrahydroberberrubine Produces Anxiolytic-Like Effects in Mice through the 5-HT1A Receptor.Buspirone reduces sexual risk-taking intent but not cocaine self-administration.The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trialDyskinesias in Parkinson's disease: views from positron emission tomography studies.Molecular imaging of levodopa-induced dyskinesias.Buspirone, a new drug for the management of patients with ineffective esophageal motility?Effects of acute buspirone administration on inhibitory control and sexual discounting in cocaine users.Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment.Modafinil decreases anxiety-like behaviour in zebrafish.Anxiety and depression in Parkinson's disease.A randomized double-blind placebo-controlled crossover-style trial of buspirone in functional dysphagia and ineffective esophageal motility.Human motoneurone excitability is depressed by activation of serotonin 1A receptors with buspirone.The Role of 5-HT1A Receptors in Long-Term Adaptation of Newborn Rats to Hypoxia.The serotonergic anxiolytic buspirone attenuates circadian responses to light.Effect of Combination of Non-Invasive Spinal Cord Electrical Stimulation and Serotonin Receptor Activation in Patients with Chronic Spinal Cord Lesion.Therapeutic doses of buspirone block D3 receptors in the living primate brain.Pd-Catalyzed Synthesis of Piperazine Scaffolds Under Aerobic and Solvent-Free Conditions.
P2860
Q26745605-9778A587-84A3-4193-9FCA-AC9C7F12EF63Q27024451-32521CE8-B3C9-42B0-B3ED-81781AA1FAC8Q30278438-39FF56C9-F22D-47F2-9F02-E7905660333FQ30560441-ADFE6F99-C086-4C19-94F0-110D492184A6Q34795714-3C07F08F-EB60-499D-A925-1E8195155496Q35330385-BED0279E-3DB1-4D19-B94B-3C19156ECA8FQ36249054-2B5F1D04-5204-4686-A1BC-2B6A4EF46371Q36976585-09E2D90C-3F18-4A5E-B5A9-BD9A8090626CQ37228686-D5873576-27F4-49A1-BA39-EBC3FA7DEC2BQ38182651-A073E571-61E6-4CF8-A164-23F3CEFE1337Q38355582-3A439ED3-6E90-4570-A0D8-C489749520CAQ38988907-92C60417-0F1A-4CA4-8275-BAC837D31C71Q39000619-E77C3593-E87E-40E6-8BCD-73D86184265FQ42072894-35FDBAD8-F31D-410C-9C1C-4E80CAAA5A9CQ42321073-36967ADC-2DAE-4BEC-AFF6-227B9934774AQ43491031-9DD575D8-3357-4EB7-8AA1-EE3FCF1C54E1Q47646970-F4E682ED-55FA-49E1-8B60-C7D673A8696BQ48032494-F50988A8-2A11-4805-8FBB-31E9C7C56D9BQ48532637-C5B945A0-9A44-47BC-A91A-6067ECD96D10Q48559635-564F0AC0-2F98-4CE7-80C0-C63D73048F31Q51360689-5E93361B-3D06-4A4A-9D95-B60080236F10Q52304391-C36F17D8-370F-4DC1-8A08-D7DBE369A21BQ54961225-B429C3AE-BC6F-4FE2-BEA2-BE13F34076E0
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Buspirone: what is it all about?
@ast
Buspirone: what is it all about?
@en
Buspirone: what is it all about?
@nl
type
label
Buspirone: what is it all about?
@ast
Buspirone: what is it all about?
@en
Buspirone: what is it all about?
@nl
prefLabel
Buspirone: what is it all about?
@ast
Buspirone: what is it all about?
@en
Buspirone: what is it all about?
@nl
P1433
P1476
Buspirone: what is it all about?
@en
P2093
P304
P356
10.1016/J.BRAINRES.2012.04.032
P407
P577
2012-04-24T00:00:00Z